What is urticaria pigmentosa?
The primary method of managing urticaria pigmentosa involves avoiding your triggers.
The primary method of managing urticaria pigmentosa involves avoiding your triggers.
Landmarks worldwide will light up on Rare Disease Day.
A recent study found that having SM may increase the risk of eclampsia but decrease the risk of abortive outcome in pregnancy.
The PATHFINDER clinical trial demonstrated that avapritinib leads to durable treatment responses and a favorable risk-benefit profile.
A 13-year-old female was diagnosed with mast cell leukemia, a type of SM, and stage IV ovarian mixed germ cell tumor.
Cogent Biosciences submitted a New Drug Application to the FDA for bezuclastinib in non-advanced SM, with future submissions planned in 2026.
Spacing out your preparation can help make the process feel less overwhelming.
A group of experts in anaphylaxis offered recommendations for epinephrin use in different patient populations, including those with SM.
Cogent Bioscience announced that their trial of bezuclastinib in patients with advanced SM showed the drug to be safe and effective.
Mast cells, which drive SM, are a type of white blood cell essential to the immune system.